Articles

Biologic therapy has proven very useful in treating an increasing number of dermatologic diseases and conditions. However, caution is warranted for patients with chronic infectious diseases. 

Dangers, Benefits of Biologics Must Be Carefully Weighed

Videos

John Browning, MD, FAAD, FAAP, MBA, discusses the impact of the recent FDA approval of secukinumab (Cosentyx, Novartis) for the treatment of moderate to severe plaque psoriasis in children and adolescents.

Secukinumab Approved for Plaque Psoriasis in Children, Adolescents

Dermavant has submitted a New Drug Application (NDA) to the FDA seeking approval for its novel topical for the treatment of mild, moderate, and severe plaque psoriasis in adult patients.

Tapinarof Cream Submitted for Approval for Treatment of Plaque Psoriasis

Secukinumab (Cosentyx, Novartis) has received FDA approval for the treatment of children and adolescents with moderate to severe plaque psoriasis. 

FDA Approves Secukinumab for Pediatric Plaque Psoriasis

AxisBiotix-Ps food supplement shows positive results in a recent consumer study evaluating its efficacy for psoriasis treatment.

Food Supplement Demonstrates Positive Results in Psoriasis Therapy

John Jesitus is a medical writer based in Westminster, CO.

Thanks to targeted drugs in early-stage development, patients with generalized pustular psoriasis (GPP) will one day likely have FDA-approved treatments for the disease, according to one expert. 

IL-36 Inhibitors on the Horizon for Generalized Pustular Psoriasis

Podcasts

In this episode, we take a look back at what happened at the American 
Academy of Dermatology Virtual Meeting Experience 2021 (AAD VMX 2021), including exclusive interviews with two KOLs about their presentations regarding climate change and new data on biologics for psoriasis. 

The Cutaneous Connection: Episode 23- Roundup of AAD VMX 2021

Novel biologics are moving into off-label indications to expand the dermatologic armamentarium for a broad range of inflammatory skin diseases.  

Off-label Biologics Target Wide Range of Skin Diseases

A new study shows a possible association between fasting and skin improvement in psoriasis patients. 

Intermittent Fasting Helps Reduce Psoriasis Symptoms

Psoriasis patients may have a higher risk of contracting COVID-19, according to study results recently presented at AAD VMX 2021. 